Online

ESTRO 2020

Session

Saturday
November 28
07:45 - 09:00
Clinical Stream 1
This house believes that Elective nodal radiotherapy should be performed for high risk prostate cancer
In patients with high-risk prostate cancer, radical radiotherapy combined with long-term androgen deprivation has been demonstrated to offer excellent long-term outcomes. Due to the risk of occult microscopic nodal metastases, elective whole pelvis nodal radiotherapy (WPRT) is often proposed for these patients for improving long-term disease control. Although modern radiotherapy techniques allow more conformal and less toxic pelvic treatments, concerns about the potential benefits of WPRT still exist. Available retrospective and prospective literature data on the role of WPRT for high-risk prostate cancer patients will be discussed and commented, focusing on the impact of modern imaging modalities, advanced radiotherapy techniques, and genomic.
1100
Debate
Clinical
09:00 - 09:15
SP-0020
09:15 - 09:30
For the motion (for ENI)
SP-0021
09:30 - 09:45
SP-0022
09:45 - 10:00
Discussion